Kore Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Kore Private Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,340	Closed	-$243K	–	450
2021 Q3	$243K	Buy	1,340 +286	+27%	+$55.8K	0.03%	379
2021 Q2	$213K	Buy	1,054 +8	+0.8%	+$1.67K	0.02%	384
2021 Q1	$225K	Buy	1,046 +162	+18%	+$35.6K	0.03%	327
2020 Q4	$209K	Buy	+884	New	+$203K	0.03%	304
2020 Q3	–	Sell	-568	Closed	-$164K	–	1061
2020 Q2	$164K	Buy	568 +67	+13%	+$18.2K	0.03%	264
2020 Q1	$119K	Buy	501 +210	+72%	+$48.2K	0.03%	287
2019 Q4	$64K	Buy	+291	New	+$58.9K	0.01%	452
2019 Q2	–	Sell	-291	Closed	-$54K	–	775
2019 Q1	$54K	Hold	291	–	–	0.01%	372
2018 Q4	$48K	Buy	+291	New	+$50.4K	0.01%	381

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Kore Private Wealth's VRTX Position: Q4 2021 in Review

Kore Private Wealth sold out of Vertex Pharmaceuticals (VRTX) in Q4 2021, closing a stake of 1,340 shares — an estimated $243K sold.

Kore Private Wealth first reported a position in VRTX in Q4 2018 and held it in 9 quarters. The position peaked at $243K in Q3 2021. 1,033 funds tracked by Wall St. Rank hold VRTX as of Q4 2021.

Kore Private Wealth reported no remaining Vertex Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Kore Private Wealth sold 1,340 Vertex Pharmaceuticals shares in Q4 2021, an estimated $243K.
Kore Private Wealth first reported a position in Vertex Pharmaceuticals in Q4 2018 and held it in 9 quarters.
Kore Private Wealth's Vertex Pharmaceuticals position peaked at $243K in Q3 2021.
1,033 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2021.

Based on Kore Private Wealth's 13F filing for Q4 2021, filed 11 Feb 2022.